Publikationen von C. Griesinger
Alle Typen
Konferenzbeitrag (15)
301.
Konferenzbeitrag
118 (3, Suppl. 1), S. 140A - 140A (2020)
Probing the accuracy of explicit solvent constant pH molecular dynamics simulations for peptides. 64th Annual Meeting of the Biophysical-Society, San Diego, CA, 15. Februar 2020 - 19. Februar 2020. Biophysical Journal 302.
Konferenzbeitrag
39 (Suppl), S. 530 - 531 (2019)
In vitro evaluation of small molecule compounds as potential PET tracers targeting a-synuclein. 29th International Symposium on Cerebral Blood Flow, Metabolism and Function / 14th International Conference on Quantification of Brain Function with PET (BRAIN and BRAIN Pet), Yokohama, Japan, 04. Juli 2019 - 07. Juli 2019. Journal of Cerebral Blood Flow and Metabolism 303.
Konferenzbeitrag
27 (Suppl_1), S. 158 - 159 (2018)
Incorporating hierarchical kinetics into determination of protein structure. 32nd Annual Symposium of the Protein-Society, Boston, MA, 09. Juli 2018 - 12. Juli 2018. Protein Science 304.
Konferenzbeitrag
The small molecule anle138b shows interaction with alpha-synuclein oligomers in phospholipid membranes. 62nd Annual Meeting of the Biophysical-Society, San Francisco, CA, 17. Februar 2018 - 21. Februar 2018. Biophysical Journal (Suppl), 3 Aufl., S. 560a - 560a (2018)
305.
Konferenzbeitrag
Three-dimensional angstrom resolution in fluorescence microscopy: Insight into protein structure. Conference on Lasers and Electro-Optics Europe / European Quantum Electronics Conference (CLEO/Europe-EQEC), München(Germany, 25. Juni 2017 - 29. Juni 2017. IEEE, (2017)
306.
Konferenzbeitrag
110 (Suppl 1), 3 Aufl., S. 420A - 420A (2016)
Effect of the novel amyloid inhibitor "anle145c" on aggregation of islet amyloid polypeptide and how it is modulated by membranes. 60th Annual Meeting of the Biophysical-Society, Los Angeles, CA, 27. Februar 2016 - 02. März 2016. Biophysical Journal 307.
Konferenzbeitrag
110 (Suppl_1), 3 Aufl., S. 221A - 221A (2016)
Allostery through protein motion at different length and time scales. 60th Annual Meeting of the Biophysical-Society, Los Angeles, CA, 27. Februar 2016 - 02. März 2016. Biophysical Journal 308.
Konferenzbeitrag
248, 447-COMP, (2014)
Rational molecular design supported by ligand-based NMR techniques. 248th National Meeting of the American-Chemical-Society (ACS), San Francisco, CA, 10. August 2014 - 14. August 2014. Abstracts of Papers of the American Chemical Society 309.
Konferenzbeitrag
21 (Suppl. 1), S. 170 - 170 (2014)
The oligomer modulator anle138b is effective in the prodromal phase of a transgenic mouse model of Parkinson's disease. Joint Congress of European Neurology, Istanbul, Turkey, 31. Mai 2014 - 03. Juni 2014. European Journal of Neurology 310.
Konferenzbeitrag
42 (Supplement 1), S. S204 - S204 (2013)
Structure of a bacterial filament solved by solid-state NMRa: The type III secretion system needle. 9th European-Biophysical-Societies-Association Congress, Lissabon/Portugal, 13. Juli 2013 - 17. Juli 2013. European Biophysics Journal with Biophysics Letters 311.
Konferenzbeitrag
104 (Supplement 1), 2 Aufl., S. 30A - 30A (2013)
Molecular recognition through concerted ubiquitin backbone and side chain motion determined from NMR and MD simulations. 57th Annual Meeting of the Biophysical-Society, Philadelphia/PA, 02. Februar 2013 - 06. Februar 2013. Biophysical Journal 312.
Konferenzbeitrag
104 (Supplement 1), 2 Aufl., S. 30A - 30A (2013)
Molecular Recognition through Concerted Ubiquitin Backbone and Side Chain Motion Determined from NMR and MD Simulations. 57th Annual Meeting of the Biophysical-Society, Philadelphia, 02. Februar 2013 - 06. Februar 2013. Biophysical Journal 313.
Konferenzbeitrag
70 (6), S. 505 - 505 (2011)
Causal therapy of prion and Parkinson's disease with novel inhibitors of protein aggregation. 87th Annual Meeting of the American Association of Neuropathologists, Seattle, WA, 23. Juni 2011 - 26. Juni 2011. Journal of Neuropathology and Experimental Neurology 314.
Konferenzbeitrag
26 (Supplement 2), S. S21 - S21 (2011)
Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor. 15th International Congress of Parkinsons Disease and Movement Disorders, Toronto, CANADA, 2011. Movement Disorders 315.
Konferenzbeitrag
88 (1), S. 396A - 396A (2005)
3D structure, ligand binding, autoinhibition, aggregation, and cellular distribution of wild-type, mutant, and labeled alpha-synuclein. Biophysical Journal Meeting Abstract (7)
316.
Meeting Abstract
279 (Supplement 1), S. 1 - 2. 22nd IUBMB Congress/37th FEBS Congress, Seville/Spain, 04. September 2012 - 09. September 2012. (2012)
Fuzzyness of globular and aggregating proteins in neurodegeneration: an NMR spectroscopic view. In FEBS Journal, 317.
Meeting Abstract
279 (Suppl. 1), P20-86, S. 433 - 433. 22nd IUBMB Congress/37th FEBS Congress, Seville/Spain, 04. September 2012 - 09. September 2012. (2012)
Functional dynamics in the voltage-dependent anion channel. In FEBS Journal, 318.
Meeting Abstract
21 (Supplement 1), S. 96 - 96. 26th Annual Symposium of the Protein-Society, San Diego, CA, 05. August 2012 - 08. August 2012. (2012)
Exceeding the limit of dynamics studies on proteins using NMR spectroscopy. In Protein Science, 319.
Meeting Abstract
21 (Supplement 1), S. 146 - 146. 26th Annual Symposium of the Protein-Society, San Diego, CA, 05. August 2012 - 08. August 2012. (2012)
Measuring the kinetics of conformational sampling during binding with NMR spectroscopy. In Protein Scinece, 320.
Meeting Abstract
78 11 Aufl., S. 1278 - 1278. International Congress on Natural Products Research on Global Change, Natural Products and Human Health/8th Joint Meeting of AFERP, ASP, GA, PSE and SIF , New York/USA, 28. Juli 2012 - 01. August 2012. (2012)
Synergistic trail sensitizers from Barleria alluaudii and Diospyros maritima. In Planta Medica,